Dr Tim Sparey
Tim is a successful, serial entrepreneur and biotech founder with extensive C-suite and board level experience in the pharmaceutical sector. In addition to working with VaxEquity Ltd as Managing Director, he is CEO of In4Derm Ltd, a University of Dundee spinout focussed on inflammation, is the chair of ConcR, and is an adviser to 3D Consultants, PanAngium Therapeutics, Cumulus Oncology and other clients. His previous biotech experiences were in multiple therapeutic and technology areas including cancer, CNS, ophthalmology and drug delivery in public and private companies including Novintum Biosciences, Midatech, Q Chip, Proximagen and Merck & Co. He has over 40 patents and publications.